Cargando...

上皮间质转化在非小细胞肺癌EGFR-TKIs耐药中的研究进展

Lung cancer is the one of the malignant tumor of the highest morbidity and mortality over the world, and non-small cell lung cancer (NSCLC) makes up about 80%. Nowadays, molecular targeted therapy has been the first-line treatment for NSCLC. Epidermal growth factor receptor-tyrosine kinase inhibitor...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Zhongguo Fei Ai Za Zhi
Formato: Artigo
Idioma:Inglês
Publicado: 中国肺癌杂志编辑部 2018
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6318572/
https://ncbi.nlm.nih.gov/pubmed/30591098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2018.12.08
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!